Huntington's disease: from pathology and genetics to potential therapies
Sara Imarisio(University of Cambridge), David C. Rubinsztein(UK Dementia Research Institute), Evangelia K. Ttofi(Addenbrooke's Hospital), J. Eric Davies(University of Cambridge), Shinji Saiki(University of Tsukuba), Claudia Rose(Addenbrooke's Hospital), Gauri Krishna(University of Cambridge), Jenny Carmichael(Northampton General Hospital), Chien‐Wen Chen(Institute of Cellular and Organismic Biology, Academia Sinica), Viktor I. Korolchuk(Newcastle University), Benjamin R. Underwood(University of Cambridge)
Cited by 412
Related Papers
A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human Organs
|Cell stem cell|2008|4k
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
|Nature Genetics|2009|3.4k
TFEB Links Autophagy to Lysosomal Biogenesis
|Science|2011|3.3k
Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease
|Nature Genetics|2004|2.3k
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
|Nature Genetics|2011|2.1k